InvestorsHub Logo
Followers 38
Posts 2912
Boards Moderated 0
Alias Born 06/05/2012

Re: 136 post# 344842

Tuesday, 02/09/2021 12:31:45 AM

Tuesday, February 09, 2021 12:31:45 AM

Post# of 403022
This not a workable licensing arrangement. Why would a BP agree to it when IPIX can then license Brilacidin via IV to a competitor to cover the flu or ABSSSI or Ebola? Then doctors can prescribe the competitors version off label to treat Covid as well.

After the Covid crisis has passed, I could see Leo signing with a BP to develop Brilacidin for innumerable diseases (bacterial, virus, parasitic, IBD, and perhaps even fungal or other conditions). But hopefully Leo is smart enough to negotiate a sliding scale of royalties that gets us to 50% after the gross reaches a billion or two.

136 said,

So we're talking potential value of licensing production/distribution of B for Cv19 exclusively?


"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."

Upton Sinclair

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News